|
Feb 25
|
Genmab A/S (GMAB): Among the Stocks That Will Go to the Moon According to Analysts
|
|
Feb 24
|
Is Genmab (GMAB) One of the Best Growth Stocks to Invest In According to Analysts?
|
|
Feb 20
|
EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma
|
|
Feb 19
|
Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference
|
|
Feb 13
|
Why Genmab (GMAB) and Sonic Automotive (SAH) Are Advancing Today
|
|
Feb 13
|
Genmab AS (GMAB) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ...
|
|
Feb 12
|
Genmab Publishes 2024 Annual Report
|
|
Jan 3
|
Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Sep 30
|
Is Genmab A/S (GMAB) One of the Best Revenue Growth Stocks to Buy According to Analysts?
|
|
Jul 29
|
All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy
|
|
Jul 25
|
GMAB vs. CSLLY: Which Stock Is the Better Value Option?
|
|
Jun 26
|
EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
|
|
Jun 12
|
Grant of Restricted Stock Units and Warrants to Employees in Genmab
|
|
Jun 1
|
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
|
|
May 23
|
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
|
|
May 22
|
Genmab acquires biotechnology company ProfoundBio in $1.8bn deal
|
|
May 21
|
Genmab Completes Acquisition of ProfoundBio
|
|
May 15
|
Market Chatter: Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'
|
|
May 14
|
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
|
|
May 14
|
Danish biotech says companies should tap into China’s ‘impressive innovation’
|